Recce Pharmaceuticals (ASX:RCE) Reports Successful Phase II Trial Results
Recce Pharmaceuticals (ASX:RCE) reports successful Phase II trial of RECCE®327 Gel, advancing to Phase III for ABSSSI treatment.
The Hub of Australian Finance News
Recce Pharmaceuticals (ASX:RCE) reports successful Phase II trial of RECCE®327 Gel, advancing to Phase III for ABSSSI treatment.
Pantoro Limited (ASX:PNR) announces strong initial drill results in Southern Mainfield, highlighting high-grade gold intersections and supporting its growth strategy.
Invictus Energy Ltd (ASX:IVZ) secures ESIA approval for pilot gas production at Cabora Bassa, advancing gas extraction and power projects in Zimbabwe.
Freightways Group (ASX:FRW) reports a 6.7% revenue increase in HY25 and announces a 19c interim dividend.
Westpac (ASX:WBC) reports a 9% decrease in net profit for 1Q25, driven by revenue changes and maintaining a strong capital position.
Adore Beauty Group Limited (ASX:ABY) reports significant profit growth and strategic advancements in H1 FY25, highlighting robust financial performance and expansion plans.
Lendlease Corporation (ASX:LLC) reports strong 1H25 results with significant operational progress and improved profitability.
BlueScope Steel Limited (ASX:BSL) reports a 7% drop in H1 FY2025 sales, declares a 30c fully franked interim dividend, and extends its share buy-back program.
The a2 Milk Company (ASX:A2M) reports 1H25 revenue growth of 10.1% and declares an interim dividend of 8.5 NZ cents per share.
The Calmer Co (ASX:CCO) secures a $2.6m FJD loan for acquiring its Navua facility, enhancing its operational capabilities.